Safety first
Guide / Research briefs

MC1R Gene Variants in Darker Skin: How Do They Affect Moles and Melanoma Risk?

Published October 28, 2026 · MTI Editorial Team · Sources linked on this page

!
Educational information only. Not medical advice and no dosing information. Melanotan I and II sold online are not FDA-approved. Talk to a licensed doctor.
MC1R Variants in Darker Skin: Moles and Melanoma Risk
Photo: "IDS-1100 Dermatoscope" by Abessemans94, CC BY-SA 4.0, via Wikimedia Commons (cropped).

Discussions around genetics and skin cancer often focus almost entirely on very pale complexions, sun burning, and red hair. However, genetic variations in pigment pathways are not exclusive to one skin tone. Understanding how these receptors function across different complexions is essential for anyone interested in skin health, tanning mechanisms, and mole safety.

What Is the Melanocortin 1 Receptor and What Does It Do?

The melanocortin 1 receptor, commonly abbreviated as MC1R, is an essential cellular receptor involved in melanin biology. In the skin, this receptor plays a crucial role in regulating melanocytes, the specialized cells responsible for producing pigment. Specifically, the melanocortin 1 receptor is vital for melanocyte proliferation, regulation, and differentiation.

When studying skin genetics and how cells respond to biological signals, researchers frequently examine variations in the gene that codes for this receptor. For an overview of this biological pathway, you can explore our guide on MC1R and Skin Pigment: How Tanning Works in the Body. In dermatological research, variations or alternate forms of this gene are known as variant alleles, and they alter how melanocytes behave in tissue.

How Are MC1R Variants Usually Understood in Fair-Skinned Individuals?

In medical literature, melanocortin 1 receptor variants are most widely recognized for their link to very light complexions. It is well established in clinical dermatology that MC1R variants can produce a fair-skinned and red-haired phenotype. Individuals with these physical traits have a strong association with an increased risk of melanoma.

Because these fair-skinned and red-haired physical features are easily recognized during clinical assessments, these patients are readily identified and given appropriate medical attention by clinicians. Their high vulnerability to ultraviolet damage and melanoma is heavily emphasized in standard health guidance. However, that high-profile connection sometimes overshadows how MC1R variants operate in individuals who do not fit that classic fair-skinned description.

Can People With Darker Skin Also Carry MC1R Gene Variants?

Yes. Although it may not be as widely appreciated, darker-skinned individuals can also carry melanocortin 1 receptor variant alleles. Having a darker complexion does not mean an individual's genetic code is devoid of these variations.

This reality was highlighted in a review titled The Melanocortin 1 receptor and its influence on naevi and melanoma in dark-skinned phenotypes, published in The Australasian journal of dermatology in 2019. The authors noted that what may not be appreciated in broader clinical awareness is that individuals with darker-skinned phenotypes can also carry variant alleles for the melanocortin 1 receptor, challenging the assumption that MC1R variants are relevant only to people with pale skin and red hair.

Does Carrying MC1R Variants Increase Melanoma Risk in Darker Skin?

According to the 2019 review, darker-skinned individuals who carry melanocortin 1 receptor variant alleles can also be at an increased risk of melanoma. While baseline melanoma incidence is historically lower in darker skin types compared to fair skin, genetic factors still influence individual biological risk.

Because the receptor is crucial for melanocyte regulation, differentiation, and proliferation, an altered receptor can alter melanocyte behavior regardless of an individual's baseline melanin level. This demonstrates why genetic susceptibility cannot be evaluated solely by looking at a person's surface complexion. You can read more about how baseline pigment interacts with ultraviolet light in our breakdown of Fitzpatrick Skin Types: What Your Skin Type Says About Burning and Tanning.

What Did the 2019 Study Explore Regarding Naevi and Melanoma Features?

The 2019 article in The Australasian journal of dermatology examined the relationship between these genetic alleles and physical skin lesions in darker skin types. A nevus (plural: naevi) is the medical term for a mole. Because MC1R is fundamental to how melanocytes proliferate and differentiate, the review centered on critical clinical questions:

  • Do the naevi of darker-skinned individuals have specific features that help identify them as carrying one of these melanocortin 1 receptor variants?
  • Do the melanomas that develop in dark-skinned melanocortin 1 receptor variant carriers possess particular clinical or biological characteristics?

These questions are vital for clinicians seeking to identify high-risk individuals through routine skin examinations before malignant growths progress.

What Were the Study Design and Limitations of This Research?

When evaluating scientific literature, it is essential to consider the format and limits of the publication to avoid overstating its conclusions:

  • Study Design: This publication is indexed in PubMed as a review article (Journal Article, Review) rather than an original, large-scale randomized trial or prospective interventional study.
  • Scope and Context: It represents a single review paper published in 2019 focusing specifically on summarizing existing questions and concepts surrounding naevi and melanoma in darker phenotypes.
  • Open Questions: The paper frames key questions regarding whether specific, reliable nevus patterns or distinctive melanoma characteristics exist in darker-skinned variant carriers, highlighting areas where further research and clinical clarification are needed rather than delivering definitive diagnostic criteria.

Because of these boundaries, readers should not interpret the review as a standalone diagnostic manual. Instead, it serves as an important scientific reminder that genetic predisposition to melanocyte dysregulation exists across different skin tones.

What Should Readers Keep in Mind for Skin Safety?

Anyone concerned about skin changes, new spots, or mole development should seek evaluation from a qualified doctor or dermatologist. Attempting to self-diagnose genetic variants or modifying skin pigment through unapproved products carries significant health risks. Unregulated peptides like melanotan I and melanotan II sold online are unapproved drugs that bypass safety testing. If you notice unusual changes in any mole or pigmented spot, schedule an exam with a medical professional.

Sources

The Melanocortin 1 receptor and its influence on naevi and melanoma in dark-skinned phenotypes. - PubMed (The Australasian journal of dermatology, 2019)

Published October 28, 2026. Sources are linked in the text. See our Medical Disclaimer.